Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood - Fetal and Neonatal Edition 2006;91:F208-F212; doi:10.1136/adc.2004.064188
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, U K
Right arrow Articles by Garland, S M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, U K
Right arrow Articles by Garland, S M
Topic Collections
Right arrowRelevant Article

REVIEW

Newer approaches to the diagnosis of early onset neonatal sepsis

U K Mishra1, S E Jacobs1, L W Doyle1,2, S M Garland2,3

1 Newborn Services, Royal Women’s Hospital, Melbourne, Victoria, Australia
2 Department of Obstetrics and Gynaecology, and Paediatrics, University of Melbourne, Melbourne
3 Department of Microbiology and Infectious Diseases, Royal Women’s and Royal Children’s Hospitals, Melbourne

Correspondence to:
Correspondence to:
Professor Garland
Clinical Microbiology and Infectious Diseases, Royal Women’s Hospital, 132 Grattan St, Carlton, Victoria 3053, Australia; suzanne.garland{at}rch.org.au


ABSTRACT
Accurate and timely diagnosis of early onset neonatal sepsis remains challenging to the clinician and the laboratory. A test with a rapid turnaround time with 100% sensitivity, rather than high specificity, which allows accurate diagnosis and appropriate antimicrobial treatment or which allows antibiotics to be safely withheld in non-infected infants, is desirable. Many potential markers (acute phase reactants, cell surface markers, cytokines) are not routinely available to the laboratory, and most likely combinations of markers will ensure greater diagnostic accuracy. In the future, molecular biology techniques offer the prospect of rapid identification of both pathogens and antimicrobial resistance markers.


Abbreviations: CRP, C reactive protein; GBS, group B streptococcus; IL, interleukin; IL1ra, IL1 receptor antagonist; PCR, polymerase chain reaction; TNF, tumour necrosis factor

Keywords: sepsis; infection; diagnosis


Relevant Article

Fantoms
Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2006 91: F157. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health